Top

European Journal of Nutrition

Published in:

01-06-2021 | Ovarian Cancer | Review

Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis

Authors: Alireza Khodavandi, Fahimeh Alizadeh, Ahmad Faizal Abdull Razis

Published in: European Journal of Nutrition | Issue 4/2021

Abstract

Purpose

It is unclear how dietary intake influences the ovarian cancer. The present paper sets out to systematically review and meta-analyze research on dietary intake to identify cases having high- or low-risk ovarian cancer.

Methods

Scopus, PubMed, and Wiley Online Libraries were searched up to the date November 24, 2019. Two reviewers were requested to independently extract study characteristics and to assess the bias and applicability risks with reference to the study inclusion criteria. Meta-analyses were performed to specify the relationship between dietary intake and the risk of ovarian cancer identifying 97 cohort studies.

Results

No significant association was found between dietary intake and risk of ovarian cancer. The results of subgroup analyses indicated that green leafy vegetables (RR = 0.91, 95%, 0.85–0.98), allium vegetables (RR = 0.79, 95% CI 0.64–0.96), fiber (RR = 0.89, 95% CI 0.81–0.98), flavonoids (RR = 0.83, 95% CI 0.78–0.89) and green tea (RR = 0.61, 95% CI 0.49–0.76) intake could significantly reduce ovarian cancer risk. Total fat (RR = 1.10, 95% CI 1.02–1.18), saturated fat (RR = 1.11, 95% CI 1.01–1.22), saturated fatty acid (RR = 1.19, 95% CI 1.04–1.36), cholesterol (RR = 1.13, 95% CI 1.04–1.22) and retinol (RR = 1.14, 95% CI 1.00–1.30) intake could significantly increase ovarian cancer risk. In addition, acrylamide, nitrate, water disinfectants and polychlorinated biphenyls were significantly associated with an increased risk of ovarian cancer.

Conclusion

These results could support recommendations to green leafy vegetables, allium vegetables, fiber, flavonoids and green tea intake for ovarian cancer prevention.

Available only for authorised users

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492CrossRefPubMed

Vargas AN (2014) Natural history of ovarian cancer. Ecancermedicalscience 8:465. https://doi.org/10.3332/ecancer.2014.465CrossRefPubMedPubMedCentral

Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH (2015) Salpingectomy as a means to reduce ovarian cancer risk. Cancer Prev Res (Phila) 8(5):342–348. https://doi.org/10.1158/1940-6207.capr-14-0293CrossRef

Schulz M, Lahmann PH, Boeing H, Hoffmann K, Allen N, Key TJA, Bingham S, Wirfält E, Berglund G, Lundin E, Hallmans G, Lukanova A, Garcia CM, González CA, Tormo MJ, Quirós JR, Ardanaz E, Larrañaga N, Lund E, Gram IT, Skeie G, Peeters PHM, Van Gils CH, Bas Bueno-De-Mesquita H, Büchner FL, Pasanisi P, Galasso R, Palli D, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Chang-Claude J, Linseisen J, Boutron-Ruault MC, Touillaud M, Clavel-Chapelon F, Olsen A, Tjønneland A, Overvad K, Tetsche M, Jenab M, Norat T, Kaaks R, Riboli E (2005) Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomark Prev 14(11 I):2531–2535. https://doi.org/10.1158/1055-9965.epi-05-0159CrossRef

Tung KH, Wilkens LR, Wu AH, McDuffie K, Hankin JH, Nomura AM, Kolonel LN, Goodman MT (2005) Association of dietary vitamin A, carotenoids, and other antioxidants with the risk of ovarian cancer. Cancer Epidemiol Biomark Prev 14(3):669–676. https://doi.org/10.1158/1055-9965.epi-04-0550CrossRef

Gifkins D, Olson SH, Paddock L, King M, Demissie K, Lu SE, Kong AN, Rodriguez-Rodriguez L, Bandera EV (2012) Total and individual antioxidant intake and risk of epithelial ovarian cancer. BMC Cancer 12:211. https://doi.org/10.1186/1471-2407-12-211CrossRefPubMedPubMedCentral

Reid BM, Permuth JB, Sellers TA (2017) Epidemiology of ovarian cancer: a review. Cancer Biol Med 14(1):9–32. https://doi.org/10.20892/j.issn.2095-3941.2016.0084CrossRefPubMedPubMedCentral

Playdon MC, Nagle CM, Ibiebele TI, Ferrucci LM, Protani MM, Carter J, Hyde SE, Neesham D, Nicklin JL, Mayne ST, Webb PM (2017) Pre-diagnosis diet and survival after a diagnosis of ovarian cancer. Br J Cancer 116(12):1627–1637. https://doi.org/10.1038/bjc.2017.120CrossRefPubMedPubMedCentral

Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, Chamosa S, Clendenen TV, Dossus L, Fortner R, Gapstur SM, Gaudet MM, Gram IT, Hartge P, Hoffman-Bolton J, Idahl A, Jones M, Kaaks R, Kirsh V, Koh WP, Lacey JV Jr, Lee IM, Lundin E, Merritt MA, Onland-Moret NC, Peters U, Poynter JN, Rinaldi S, Robien K, Rohan T, Sandler DP, Schairer C, Schouten LJ, Sjoholm LK, Sieri S, Swerdlow A, Tjonneland A, Travis R, Trichopoulou A, van den Brandt PA, Wilkens L, Wolk A, Yang HP, Zeleniuch-Jacquotte A, Tworoger SS (2016) Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium. J Clin Oncol 34(24):2888–2898. https://doi.org/10.1200/jco.2016.66.8178CrossRefPubMedPubMedCentral

10.

Jia D, Nagaoka Y, Katsumata M, Orsulic S (2018) Inflammation is a key contributor to ovarian cancer cell seeding. Sci Rep 8(1):12394. https://doi.org/10.1038/s41598-018-30261-8CrossRefPubMedPubMedCentral

11.

Jiang L, Fang X, Wang H, Li D, Wang X (2018) Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells. Front Immunol 9:2927. https://doi.org/10.3389/fimmu.2018.02927CrossRefPubMedPubMedCentral

12.

Longuespee R, Boyon C, Desmons A, Vinatier D, Leblanc E, Farre I, Wisztorski M, Ly K, D’Anjou F, Day R, Fournier I, Salzet M (2012) Ovarian cancer molecular pathology. Cancer Metastasis Rev 31(3–4):713–732. https://doi.org/10.1007/s10555-012-9383-7CrossRefPubMed

13.

Harrington BS, Annunziata CM (2019) NF-κB signaling in ovarian cancer. Cancers (Basel) 11(8):1182. https://doi.org/10.3390/cancers11081182CrossRef

14.

Ghoneum A, Said N (2019) PI3K-AKT-mTOR and NFκB pathways in ovarian cancer: implications for targeted therapeutics. Cancers (Basel) 11(7):949. https://doi.org/10.3390/cancers11070949CrossRef

15.

Tschernichovsky R, Goodman A (2017) Risk-reducing strategies for ovarian cancer in BRCA mutation carriers: a balancing act. Oncologist 22(4):450–459. https://doi.org/10.1634/theoncologist.2016-0444CrossRefPubMedPubMedCentral

16.

Committee on Practice Bulletins–Gynecology C, Park J (2019) Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome. Obstet Gynecol 130(3):e110–e126. https://doi.org/10.1097/aog.0000000000002296CrossRef

17.

Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng CW (2018) Screening for ovarian cancer: US Preventive Services Task Force recommendation statement. J Am Med Assoc 319(6):588–594. https://doi.org/10.1001/jama.2017.21926CrossRef

18.

Koushik A, Hunter DJ, Spiegelman D, Anderson KE, Arslan AA, Beeson WL, Van Den Brandt PA, Buring JE, Cerhan JR, Colditz GA, Fraser GE, Freudenheim JL, Genkinger JM, Goldbohm RA, Hankinson SE, Koenig KL, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Patel A, Rohan TE, Schatzkin A, Smit E, Willett WC, Wolk A, Zhang SM, Smith-Warner SA (2005) Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomark Prev 14(9):2160–2167. https://doi.org/10.1158/1055-9965.EPI-05-0218CrossRef

19.

Alvarez RD, Karlan BY, Strauss JF (2016) Ovarian cancers: evolving paradigms in research and care: report from the Institute of Medicine. Gynecol Oncol 141(3):413–415. https://doi.org/10.1016/j.ygyno.2016.04.541CrossRefPubMed

20.

Sakauchi F, Khan MM, Mori M, Kubo T, Fujino Y, Suzuki S, Tokudome S, Tamakoshi A (2007) Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer 57(2):138–145. https://doi.org/10.1080/01635580701274178CrossRefPubMed

21.

Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK (2009) Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol 3(2):97–137. https://doi.org/10.1016/j.molonc.2009.02.004CrossRefPubMedPubMedCentral

22.

National Comprehensive Cancer Network (NCCN) (2018) NCCN clinical practice guiedlines in oncology (NCCN Guiedlines®) for ovarian cancer including fallopian tube cancer and primary peritoneal cancer, version 2 2018

23.

Ovarian cancer causes, risk factors, and prevention. https://www.cancer.org/cancer/ovarian-cancer/causes-risks-prevention/risk-factors.html. Accessed 11 April 2018

24.

Schulz M, Lahmann PH, Riboli E, Boeing H (2004) Dietary determinants of epithelial ovarian cancer: a review of the epidemiologic literature. Nutr Cancer 50(2):120–140. https://doi.org/10.1207/s15327914nc5002_2CrossRefPubMed

25.

Crane TE, Khulpateea BR, Alberts DS, Basen-Engquist K, Thomson CA (2014) Dietary intake and ovarian cancer risk: a systematic review. Cancer Epidemiol Biomark Prev 23(2):255–273. https://doi.org/10.1158/1055-9965.EPI-13-0515CrossRef

26.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

27.

Aune D, Rosenblatt DAN, Chan DSM, Abar L, Vingeliene S, Vieira AR, Greenwood DC, Norat T (2015) Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer 136(8):1888–1898. https://doi.org/10.1002/ijc.29207CrossRefPubMed

28.

Nieuwenhuis L, van den Brandt PA (2019) Nut and peanut butter intake are not directly associated with the risk of endometrial or ovarian cancer: results from a Dutch prospective cohort study. Clin Nutr. https://doi.org/10.1016/j.clnu.2019.09.008CrossRefPubMed

29.

Dunneram Y, Greenwood DC, Cade JE (2018) Diet and risk of breast, endometrial and ovarian cancer: UK Women’s Cohort Study. Br J Nutr. https://doi.org/10.1017/s0007114518003665CrossRefPubMedPubMedCentral

30.

Merritt MA, Tzoulaki I, Van Den Brandt PA, Schouten LJ, Tsilidis KK, Weiderpass E, Patel CJ, Tjønneland A, Hansen L, Overvad K, His M, Dartois L, Boutron-Ruault MC, Fortner RT, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Palli D, Krogh V, Tumino R, Ricceri F, Mattiello A, Bas Bueno-De-Mesquita H, Charlotte Onland-Moret N, Peeters PH, Skeie G, Jareid M, Ramón Quirós J, Obón-Santacana M, Sánchez MJ, Chamosa S, Huerta JM, Barricarte A, Dias JA, Sonestedt E, Idahl A, Lundin E, Wareham NJ, Khaw KT, Travis RC, Ferrari P, Riboli E, Gunter MJ (2016) Nutrient-wide association study of 57 foods/nutrients and epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. Am J Clin Nutr 103(1):161–167. https://doi.org/10.3945/ajcn.115.118588CrossRefPubMed

31.

Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E (2011) Dietary phytoestrogens and the risk of ovarian cancer in the women’s lifestyle and health cohort study. Cancer Epidemiol Biomark Prev 20(2):308–317. https://doi.org/10.1158/1055-9965.epi-10-0752CrossRef

32.

Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, Davis FG (2010) Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer. J Am Diet Assoc 110(3):369–382. https://doi.org/10.1016/j.jada.2009.11.014CrossRefPubMed

33.

Key TJ, Appleby PN, Spencer EA, Travis RC, Allen NE, Thorogood M, Mann JI (2009) Cancer incidence in British vegetarians. Br J Cancer 101(1):192–197. https://doi.org/10.1038/sj.bjc.6605098CrossRefPubMedPubMedCentral

34.

George SM, Park Y, Leitzmann MF, Freedman ND, Dowling EC, Reedy J, Schatzkin A, Hollenbeck A, Subar AF (2009) Fruit and vegetable intake and risk of cancer: a prospective cohort study. Am J Clin Nutr 89(1):347–353. https://doi.org/10.3945/ajcn.2008.26722CrossRefPubMed

35.

Chang ET, Lee VS, Canchola AJ, Dalvi TB, Clarke CA, Reynolds P, Purdie DM, Stram DO, West DW, Ziogas A, Bernstein L, Horn-Ross PL (2008) Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort. Nutr Cancer 60(3):285–291. https://doi.org/10.1080/01635580701733091CrossRefPubMedPubMedCentral

36.

Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, Stram DO, West DW, Wright W, Ziogas A, Horn-Ross PL (2007) Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165(7):802–813. https://doi.org/10.1093/aje/kwk065CrossRefPubMed

37.

Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE (2007) A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121(10):2225–2232. https://doi.org/10.1002/ijc.22790CrossRefPubMed

38.

Kiani F, Knutsen S, Singh P, Ursin G, Fraser G (2006) Dietary risk factors for ovarian cancer: the adventist health study (United States). Cancer Causes Control 17(2):137–146. https://doi.org/10.1007/s10552-005-5383-zCrossRefPubMed

39.

Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA (2005) Consumption of vegetables and fruits and risk of ovarian carcinoma. Cancer 104(7):1512–1519. https://doi.org/10.1002/cncr.21332CrossRefPubMed

40.

Larsson SC, Holmberg L, Wolk A (2004) Fruit and vegetable consumption in relation to ovarian cancer incidence: the Swedish Mammography Cohort. Br J Cancer 90(11):2167–2170. https://doi.org/10.1038/sj.bjc.6601872CrossRefPubMedPubMedCentral

41.

Bertone ER, Rosner BA, Hunter DJ, Stampfer MJ, Speizer FE, Colditz GA, Willett WC, Hankinson SE (2002) Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol 156(1):22–31. https://doi.org/10.1093/aje/kwf008CrossRefPubMed

42.

Fairfield KM, Hankinson SE, Rosner BA, Hunter DJ, Colditz GA, Willett WC (2001) Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids: a prospective analysis. Cancer 92(9):2318–2326. https://doi.org/10.1002/1097-0142(20011101)92:9%3c2318:AID-CNCR1578%3e3.0.CO;2-7CrossRefPubMed

43.

Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, Sellers TA (1999) Prospective study of diet and ovarian cancer. Am J Epidemiol 149(1):21–31. https://doi.org/10.1093/oxfordjournals.aje.a009723CrossRefPubMed

44.

Gilsing AMJ, Weijenberg MP, Goldbohm RA, Van Den Brandt PA, Schouten LJ (2011) Consumption of dietary fat and meat and risk of ovarian cancer in the Netherlands Cohort Study. Am J Clin Nutr 93(1):118–126. https://doi.org/10.3945/ajcn.2010.29888CrossRefPubMed

45.

Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R (2011) Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res 4(11):1903–1911. https://doi.org/10.1158/1940-6207.CAPR-11-0241CrossRef

46.

Schulz M, Nöthlings U, Allen N, Onland-Moret NC, Agnoli C, Engeset D, Galasso R, Wirfält E, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Chajes V, Clavel-Chapelon F, Ray J, Hoffmann K, Chang-Claude J, Kaaks R, Trichopoulos D, Georgila C, Zourna P, Palli D, Berrino F, Tumino R, Vineis P, Panico S, Bueno-De-Mesquita HB, Ocké MC, Peeters PHM, Lund E, Gram IT, Skeie G, Berglund G, Lundin E, Hallmans G, González CA, Quirós JR, Dorronsoro M, Martínez C, Tormo MJ, Barricarte A, Bingham S, Khaw KT, Key TJA, Jenab M, Rinaldi S, Slimani N, Riboli E (2007) No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomark Prev 16(4):852–855. https://doi.org/10.1158/1055-9965.EPI-07-0054CrossRef

47.

Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R (2007) A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 4(12):e325. https://doi.org/10.1371/journal.pmed.0040325CrossRefPubMedPubMedCentral

48.

Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Beeson WL, Buring JE, Colditz GA, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Koenig KL, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Ross JA, Schatzkin A, Schouten LJ, Smit E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Smith-Warner SA (2006) A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer. Cancer Causes Control 17(3):273–285. https://doi.org/10.1007/s10552-005-0455-7CrossRefPubMed

49.

Larsson SC, Wolk A (2005) No association of meat, fish, and egg consumption with ovarian cancer risk. Cancer Epidemiol Biomark Prev 14(4):1024–1025. https://doi.org/10.1158/1055-9965.EPI-04-0795CrossRef

50.

Knekt P, Steineck G, Jarvinen R, Hakulinen T, Aromaa A (1994) Intake of fried meat and risk of cancer: a follow-up study in Finland. Int J Cancer 59:756–760CrossRefPubMed

51.

Merritt MA, Poole EM, Hankinson SE, Willett WC, Tworoger SS (2014) Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer. Cancer Causes Control 25(7):795–808. https://doi.org/10.1007/s10552-014-0381-7CrossRefPubMedPubMedCentral

52.

Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A (2009) Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med 169(4):391–401. https://doi.org/10.1001/archinternmed.2008.578CrossRefPubMedPubMedCentral

53.

Koralek DO, Bertone-Johnson ER, Leitzmann MF, Sturgeon SR, Lacey JV Jr, Schairer C, Schatzkin A (2006) Relationship between calcium, lactose, vitamin D, and dairy products and ovarian cancer. Nutr Cancer 56(1):22–30. https://doi.org/10.1207/s15327914nc5601_4CrossRefPubMed

54.

Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA (2006) Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 94(1):165–170. https://doi.org/10.1038/sj.bjc.6602890CrossRefPubMed

55.

Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, Buring JE, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Jacobs DR Jr, Koushik A, Lacey JV Jr, Larsson SC, Leitzmann M, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Scheuten LJ, Shore R, Smit E, Wolk A, Zhang SM, Smith-Warner SA (2006) Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomark Prev 15(2):364–372. https://doi.org/10.1158/1055-9965.EPI-05-0484CrossRef

56.

Fairfield KM, Hunter DJ, Colditz GA, Fuchs CS, Cramer DW, Speizer FE, Willett WC, Hankinson SE (2004) A prospective study of dietary lactose and ovarian cancer. Int J Cancer 110(2):271–277. https://doi.org/10.1002/ijc.20086CrossRefPubMed

57.

Larsson SC, Bergkvist L, Wolk A (2004) Milk and lactose intakes and ovarian cancer risk in the Swedish Mammography Cohort. Am J Clin Nutr 80(5):1353–1357. https://doi.org/10.1093/ajcn/80.5.1353CrossRefPubMed

58.

Rice MS, Poole EM, Willett WC, Tworoger SS (2019) Adult dietary fat intake and ovarian cancer risk. Int J Cancer. https://doi.org/10.1002/ijc.32635CrossRefPubMedPubMedCentral

59.

Merritt MA, Riboli E, Weiderpass E, Tsilidis KK, Overvad K, Tjonneland A, Hansen L, Dossus L, Fagherazzi G, Baglietto L, Fortner RT, Ose J, Steffen A, Boeing H, Trichopoulou A, Trichopoulos D, Lagiou P, Masala G, Sieri S, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Hjartaker A, Gram IT, Quiros JR, Obon-Santacana M, Molina-Montes E, Huerta Castano JM, Ardanaz E, Chamosa S, Sonestedt E, Idahl A, Lundin E, Khaw KT, Wareham N, Travis RC, Rinaldi S, Romieu I, Chajes V, Gunter MJ (2014) Dietary fat intake and risk of epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol 38(5):528–537. https://doi.org/10.1016/j.canep.2014.07.011CrossRefPubMed

60.

Laake I, Carlsen MH, Pedersen JI, Weiderpass E, Selmer R, Kirkhus B, Thune I, Veierød MB (2013) Intake of trans fatty acids from partially hydrogenated vegetable and fish oils and ruminant fat in relation to cancer risk. Int J Cancer 132(6):1389–1403. https://doi.org/10.1002/ijc.27737CrossRefPubMed

61.

Blank MM, Wentzensen N, Murphy MA, Hollenbeck A, Park Y (2012) Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study. Br J Cancer 106(3):596–602. https://doi.org/10.1038/bjc.2011.572CrossRefPubMedPubMedCentral

62.

Arthur R, Brasky TM, Crane TE, Felix AS, Kaunitz AM, Shadyab AH, Qi L, Wassertheil-Smoller S, Rohan TE (2019) Associations of a healthy lifestyle index with the risks of endometrial and ovarian cancer among women in the Women’s Health Initiative Study. Am J Epidemiol 188(2):261–273. https://doi.org/10.1093/aje/kwy249CrossRefPubMed

63.

Arthur R, Kirsh VA, Kreiger N, Rohan T (2018) A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women. Cancer Causes Control 29(6):485–493. https://doi.org/10.1007/s10552-018-1032-1CrossRefPubMed

64.

Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, Hartge P, Hollenbeck A, Park Y, Wentzensen N (2012) Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study. Int J Cancer 131(4):938–948. https://doi.org/10.1002/ijc.26469CrossRefPubMed

65.

Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan—results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40(1):21–30. https://doi.org/10.3892/ijo.2011.1194CrossRefPubMed

66.

Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, Green J (2009) Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 101(5):296–305. https://doi.org/10.1093/jnci/djn514CrossRefPubMed

67.

Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE (2008) Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 112(5):1169–1177. https://doi.org/10.1002/cncr.23275CrossRefPubMed

68.

Kabat GC, Miller AB, Jain M, Rohan TE (2008) Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer 99(5):816–821. https://doi.org/10.1038/sj.bjc.6604540CrossRefPubMedPubMedCentral

69.

Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, Bernstein L, Stram DO, Anton-Culver H, Deapen D, Mohrenweiser H, Peel D, Pinder R, Ross RK, West DW, Wright W, Ziogas A, Horn-Ross PL (2007) Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 18(1):91–103. https://doi.org/10.1007/s10552-006-0083-xCrossRefPubMedPubMedCentral

70.

Navarro Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2006) Dietary folate consumption and risk of ovarian cancer: a prospective cohort study. Eur J Cancer Prev 15(6):511–515. https://doi.org/10.1097/01.cej.0000220627.54986.bfCrossRefPubMed

71.

Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, Goldbohm RA, Harnack L, Hankinson SE, Larsson SC, Leitzmann M, McCullough ML, Marshall J, Miller AB, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ, Wolk A, Zhang SM, Smith-Warner SA (2006) Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 94(5):757–762. https://doi.org/10.1038/sj.bjc.6603020CrossRefPubMedPubMedCentral

72.

Tworoger SS, Hecht JL, Giovannucci E, Hankinson SE (2006) Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer. Am J Epidemiol 163(12):1101–1111. https://doi.org/10.1093/aje/kwj128CrossRefPubMed

73.

Schouten LJ, Zeegers MPA, Goldbohm RA, Van Den Brandt PA (2004) Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 15(2):201–209. https://doi.org/10.1023/B:CACO.0000019512.71560.2bCrossRefPubMed

74.

Larsson SC, Wolk A (2004) Wine consumption and epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 13(11Pt1):1823–1824

75.

Kelemen LE, Sellers TA, Vierkant RA, Harnack L, Cerhan JR (2004) Association of folate and alcohol with risk of ovarian cancer in a prospective study of postmenopausal women. Cancer Causes Control 15(10):1085–1093. https://doi.org/10.1007/s10552-004-1546-6CrossRefPubMed

76.

Larsson SC, Giovannucci E, Wolk A (2004) Dietary folate intake and incidence of ovarian cancer: the Swedish mammography cohort. J Natl Cancer Inst 96(5):396–402. https://doi.org/10.1093/jnci/djh061CrossRefPubMed

77.

Arthur RS, Kirsh VA, Rohan TE (2019) Dietary B-vitamin intake and risk of breast, endometrial, ovarian and colorectal cancer among Canadians. Nutr Cancer 71(7):1067–1077. https://doi.org/10.1080/01635581.2019.1597904CrossRefPubMed

78.

Koushik A, Wang M, Anderson KE, van den Brandt P, Clendenen TV, Eliassen AH, Freudenheim JL, Genkinger JM, Håkansson N, Marshall JR, McCullough ML, Miller AB, Robien K, Rohan TE, Schairer C, Schouten LJ, Tworoger SS, Wang Y, Wolk A, Zeleniuch-Jacquotte A, Smith-Warner SA (2015) Intake of vitamins A, C, and E and folate and the risk of ovarian cancer in a pooled analysis of 10 cohort studies. Cancer Causes Control 26(9):1315–1327. https://doi.org/10.1007/s10552-015-0626-0CrossRefPubMedPubMedCentral

79.

Cassidy A, Huang T, Rice MS, Rimm EB, Tworoger SS (2014) Intake of dietary flavonoids and risk of epithelial ovarian cancer. Am J Clin Nutr 100(5):1344–1351. https://doi.org/10.3945/ajcn.114.088708CrossRefPubMedPubMedCentral

80.

Prescott J, Bertrand KA, Poole EM, Rosner BA, Tworoger SS (2013) Surrogates of long-term vitamin D exposure and ovarian cancer risk in two prospective cohort studies. Cancers (Basel) 5(4):1577–1600. https://doi.org/10.3390/cancers5041577CrossRef

81.

Kotsopoulos J, Hankinson SE, Tworoger SS (2010) Dietary betaine and choline intake are not associated with risk of epithelial ovarian cancer. Eur J Clin Nutr 64(1):111–114. https://doi.org/10.1038/ejcn.2009.109CrossRefPubMed

82.

Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD (2009) Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89(3):905–912. https://doi.org/10.3945/ajcn.2008.26913CrossRefPubMedPubMedCentral

83.

Thomson CA, Neuhouser ML, Shikany JM, Caan BJ, Monk BJ, Mossavar-Rahmani Y, Sarto G, Parker LM, Modugno F, Anderson GL (2008) The role of antioxidants and vitamin A in ovarian cancer: results from the women’s health initiative. Nutr Cancer 60(6):710–719. https://doi.org/10.1080/01635580802233983CrossRefPubMed

84.

Silvera SAN, Jain M, Howe GR, Miller AB, Rohan TE (2007) Dietary fiber intake and ovarian cancer risk: a prospective cohort study. Cancer Causes Control 18(3):335–341. https://doi.org/10.1007/s10552-006-0107-6CrossRefPubMed

85.

Koushik A, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, Goldbohm RA, Hankinson SE, Larsson SC, Leitzmann M, Marshall JR, McCullough ML, Miller AB, Rodriguez C, Rohan TE, Ross JA, Schatzkin A, Schouten LJ, Willett WC, Wolk A, Zhang SM, Smith-Warner SA (2006) Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies. Int J Cancer 119(9):2148–2154. https://doi.org/10.1002/ijc.22076CrossRefPubMed

86.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2006) Carotenoid, vitamin A, vitamin C, and vitamin E intake and risk of ovarian cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 15(2):395–397. https://doi.org/10.1158/1055-9965.epi-05-0835CrossRef

87.

Arts IC, Jacobs DR Jr, Gross M, Harnack LJ, Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women’s Health Study (United States). Cancer Causes Control 13(4):373–382CrossRefPubMed

88.

Arthur R, Kirsh VA, Rohan TE (2018) Associations of coffee, tea and caffeine intake with risk of breast, endometrial and ovarian cancer among Canadian women. Cancer Epidemiol 56:75–82. https://doi.org/10.1016/j.canep.2018.07.013CrossRefPubMed

89.

Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW (2018) Prospective study of coffee consumption and cancer incidence in non-white populations. Cancer Epidemiol Biomark Prev 27(8):928–935. https://doi.org/10.1158/1055-9965.epi-18-0093CrossRef

90.

Gunter MJ, Murphy N, Cross AJ, Dossus L, Dartois L, Fagherazzi G, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Tjønneland A, Olsen A, Overvad K, Larsen SC, Cornejo MLR, Agudo A, Pérez MJS, Altzibar JM, Navarro C, Ardanaz E, Khaw KT, Butterworth A, Bradbury KE, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Vineis P, Panico S, Tumino R, Bueno-De-Mesquita B, Siersema P, Leenders M, Beulens JWJ, Uiterwaal CU, Wallström P, Nilsson LM, Landberg R, Weiderpass E, Skeie G, Braaten T, Brennan P, Licaj I, Muller DC, Sinha R, Wareham N, Riboli E (2017) Coffee drinking and mortality in 10 European countries: a multinational cohort study. Ann Intern Med 167(4):236–247. https://doi.org/10.7326/M16-2945CrossRefPubMedPubMedCentral

91.

Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T (2016) Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol 31(9):905–916. https://doi.org/10.1007/s10654-016-0142-xCrossRefPubMed

92.

Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang ZF, La Vecchia C (2015) Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 113(5):809–816. https://doi.org/10.1038/bjc.2015.276CrossRefPubMedPubMedCentral

93.

Braem MGM, Onland-Moret NC, Schouten LJ, Tjønneland A, Hansen L, Dahm CC, Overvad K, Lukanova A, Dossus L, Floegel A, Boeing H, Clavel-Chapelon F, Chabbert-Buffet N, Fagherazzi G, Trichopoulou A, Benetou V, Goufa I, Pala V, Galasso R, Mattiello A, Sacerdote C, Palli D, Tumino R, Gram IT, Lund E, Gavrilyuk O, Sánchez MJ, Quirós R, Gonzales CA, Dorronsoro M, Huerta Castaño JM, Gurrea AB, Idahl A, Ohlson N, Lundin E, Jirstrom K, Wirfalt E, Allen NE, Tsilidis KK, Kaw KT, Bueno-de-Mesquita HB, Dik VK, Rinaldi S, Fedirko V, Norat T, Riboli E, Kaaks R, Peeters PHM (2012) Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr 95(5):1172–1181. https://doi.org/10.3945/ajcn.111.026393CrossRefPubMed

94.

Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B (2010) Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21(10):1533–1544. https://doi.org/10.1007/s10552-010-9582-xCrossRefPubMed

95.

Lueth NA, Anderson KE, Harnack LJ, Fulkerson JA, Robien K (2008) Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women’s Health Study. Cancer Causes Control 19(10):1365–1372. https://doi.org/10.1007/s10552-008-9208-8CrossRefPubMedPubMedCentral

96.

Steevens J, Schouten LJ, Verhage BAJ, Goldbohm RA, Van Den Brandt PA (2007) Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 97(9):1291–1294. https://doi.org/10.1038/sj.bjc.6604008CrossRefPubMedPubMedCentral

97.

Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE (2007) Intake of coffee and tea and risk of ovarian cancer: a prospective cohort study. Nutr Cancer 58(1):22–27. https://doi.org/10.1080/01635580701307945CrossRefPubMed

98.

Larsson SC, Wolk A (2005) Coffee consumption is not associated with ovarian cancer incidence. Cancer Epidemiol Biomark Prev 14(9):2273–2274. https://doi.org/10.1158/1055-9965.EPI-05-0280CrossRef

99.

Larsson SC, Wolk A (2005) Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 165(22):2683–2686. https://doi.org/10.1001/archinte.165.22.2683CrossRefPubMed

100.

Zhang M, Lee AH, Binns CW, Xie X (2004) Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 112(3):465–469. https://doi.org/10.1002/ijc.20456CrossRefPubMed

101.

Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR (1996) Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144(2):175–182CrossRefPubMed

102.

Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5):401–408CrossRefPubMed

103.

Jacobsen BK, Bjelke E, Kvåle G, Heuch I (1986) Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76(5):823–831PubMed

104.

Snowdon DA, Phillips RL (1984) Coffee consumption and risk of fatal cancers. Am J Public Health 74(8):820–823CrossRefPubMedPubMedCentral

105.

Kotemori A, Ishihara J, Zha L, Liu R, Sawada N, Iwasaki M, Sobue T, Tsugane S (2018) Dietary acrylamide intake and the risk of endometrial or ovarian cancers in Japanese women. Cancer Sci 109(10):3316–3325. https://doi.org/10.1111/cas.13757CrossRefPubMedPubMedCentral

106.

Inoue-Choi M, Weyer PJ, Jones RR, Booth BJ, Cantor KP, Robien K, Ward MH (2016) Atrazine in public water supplies and risk of ovarian cancer among postmenopausal women in the Iowa Women’s Health Study. Occup Environ Med 73(9):582–587. https://doi.org/10.1136/oemed-2016-103575CrossRefPubMed

107.

Donat-Vargas C, Akesson A, Berglund M, Glynn A, Wolk A, Kippler M (2016) Dietary exposure to polychlorinated biphenyls and risk of breast, endometrial and ovarian cancer in a prospective cohort. Br J Cancer 115(9):1113–1121. https://doi.org/10.1038/bjc.2016.282CrossRefPubMedPubMedCentral

108.

Obón-Santacana M, Peeters PHM, Freisling H, Dossus L, Clavel-Chapelon F, Baglietto L, Schock H, Fortner RT, Boeing H, Tjønneland A, Olsen A, Overvad K, Menéndez V, Sanchez MJ, Larrañaga N, Castaño JMH, Barricarte A, Khaw KT, Wareham N, Travis RC, Merritt MA, Trichopoulou A, Trichopoulos D, Orfanos P, Masala G, Sieri S, Tumino R, Vineis P, Mattiello A, Bueno-De-Mesquita HB, Onland-Moret NC, Wirfält E, Stocks T, Idahl A, Lundin E, Skeie G, Gram IT, Weiderpass E, Riboli E, Duell EJ (2015) Dietary intake of acrylamide and epithelial ovarian cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. Cancer Epidemiol Biomark Prev 24(1):291–297. https://doi.org/10.1158/1055-9965.EPI-14-0636CrossRef

109.

Inoue-Choi M, Jones RR, Anderson KE, Cantor KP, Cerhan JR, Krasner S, Robien K, Weyer PJ, Ward MH (2015) Nitrate and nitrite ingestion and risk of ovarian cancer among postmenopausal women in Iowa. Int J Cancer 137(1):173–182. https://doi.org/10.1002/ijc.29365CrossRefPubMed

110.

Adams SV, Quraishi SM, Shafer MM, Passarelli MN, Freney EP, Chlebowski RT, Luo J, Meliker JR, Mu L, Neuhouser ML, Newcomb PA (2014) Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women’s Health Initiative. Environ Health Perspect 122(6):594–600. https://doi.org/10.1289/ehp.1307054CrossRefPubMedPubMedCentral

111.

Eriksen KT, Halkjær J, Sørensen M, Meliker JR, McElroy JA, Tjønneland A, Raaschou-Nielsen O (2014) Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study. PloS One 9(6):e100815. https://doi.org/10.1371/journal.pone.0100815CrossRefPubMedPubMedCentral

112.

Aschebrook-Kilfoy B, Ward MH, Gierach GL, Schatzkin A, Hollenbeck AR, Sinha R, Cross AJ (2012) Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Eur J Cancer Prev 21(1):65–72. https://doi.org/10.1097/CEJ.0b013e328347622fCrossRefPubMedPubMedCentral

113.

Loh YH, Jakszyn P, Luben RN, Mulligan AA, Mitrou PN, Khaw KT (2011) N-nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Am J Clin Nutr 93(5):1053–1061. https://doi.org/10.3945/ajcn.111.012377CrossRefPubMed

114.

Julin B, Wolk A, Åkesson A (2011) Dietary cadmium exposure and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Br J Cancer 105(3):441–444. https://doi.org/10.1038/bjc.2011.238CrossRefPubMedPubMedCentral

115.

Wilson KM, Mucci LA, Rosner BA, Willett WC (2010) A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomark Prev 19(10):2503–2515. https://doi.org/10.1158/1055-9965.epi-10-0391CrossRef

116.

Larsson SC, Akesson A, Wolk A (2009) Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomark Prev 18(3):994–997. https://doi.org/10.1158/1055-9965.epi-08-0868CrossRef

117.

Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, Van Den Brandt PA (2007) A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomark Prev 16(11):2304–2313. https://doi.org/10.1158/1055-9965.EPI-07-0581CrossRef

118.

Weyer PJ, Cerhan JR, Kross BC, Hallberg GR, Kantamneni J, Breuer G, Jones MP, Zheng W, Lynch CF (2001) Municipal drinking water nitrate level and cancer risk in older women: the Iowa women’s health study. Epidemiology 12(3):327–338. https://doi.org/10.1097/00001648-200105000-00013CrossRefPubMed

119.

Tasevska N, Jiao L, Cross AJ, Kipnis V, Subar AF, Hollenbeck A, Schatzkin A, Potischman N (2012) Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer 130(1):159–169. https://doi.org/10.1002/ijc.25990CrossRefPubMed

120.

Silvera SAN, Jain M, Howe GR, Miller AB, Rohan TE (2007) Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study. Public Health Nutr 10(10):1076–1081. https://doi.org/10.1017/S1368980007696360CrossRefPubMed

121.

World Cancer Research Fund/American Institute for Cancer Research: diet, nutrition, physical activity and ovarian cancer. Continuous Update Project Expert Report (2018) https://www.wcrf.org/dietandcancer/ovarian-cancer. Accessed 17 May 2019

122.

Qu XL, Fang Y, Zhang M, Zhang YZ (2014) Phytoestrogen intake and risk of ovarian cancer: a meta-analysis of 10 observational studies. Asian Pac J Cancer Prev 15(21):9085–9091. https://doi.org/10.7314/APJCP.2014.15.21.9085CrossRefPubMed

123.

Myung SK, Ju W, Choi HJ, Kim SC (2009) Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG Int J Obs Gynaecol 116(13):1697–1705. https://doi.org/10.1111/j.1471-0528.2009.02322.xCrossRef

124.

Hu J, Hu Y, Hu Y, Zheng S (2015) Intake of cruciferous vegetables is associated with reduced risk of ovarian cancer: a meta-analysis. Asia Pac J Clin Nutr 24(1):101–109. https://doi.org/10.6133/apjcn.2015.24.1.22CrossRefPubMed

125.

Song X, Li Z, Ji X, Zhang D (2017) Calcium intake and the risk of ovarian cancer: a meta-analysis. Nutrients 9(7):679. https://doi.org/10.3390/nu9070679CrossRefPubMedCentral

126.

Huang X, Wang X, Shang J, Lin Y, Yang Y, Song Y, Yu S (2018) Association between dietary fiber intake and risk of ovarian cancer: a meta-analysis of observational studies. J Int Med Res 46(10):3995–4005. https://doi.org/10.1177/0300060518792801CrossRefPubMedPubMedCentral

127.

Xu H, Ding Y, Xin X, Wang W, Zhang D (2018) Dietary fiber intake is associated with a reduced risk of ovarian cancer: a dose-response meta-analysis. Nutr Res 57:1–11. https://doi.org/10.1016/j.nutres.2018.04.011CrossRefPubMed

128.

Li X, Xu J (2014) Meta-analysis of the association between dietary lycopene intake and ovarian cancer risk in postmenopausal women. Sci Rep. https://doi.org/10.1038/srep04885CrossRefPubMedPubMedCentral

129.

Zhan X, Wang J, Pan S, Lu C (2017) Tea consumption and the risk of ovarian cancer: a meta-analysis of epidemiological studies. Oncotarget 8(23):37796–37806. https://doi.org/10.18632/oncotarget.16890CrossRefPubMedPubMedCentral

130.

Butler LM, Wu AH (2011) Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res 55(6):931–940. https://doi.org/10.1002/mnfr.201100058CrossRefPubMedPubMedCentral

131.

Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18(1):1–29. https://doi.org/10.1080/01635589209514201CrossRefPubMed

132.

Wu QJ, Yang Y, Vogtmann E, Wang J, Han LH, Li HL, Xiang YB (2013) Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Ann Oncol 24(4):1079–1087. https://doi.org/10.1093/annonc/mds601CrossRefPubMed

133.

Wang Q, Chen Y, Wang X, Gong G, Li G, Li C (2014) Consumption of fruit, but not vegetables, may reduce risk of gastric cancer: results from a meta-analysis of cohort studies. Eur J Cancer 50(8):1498–1509. https://doi.org/10.1016/j.ejca.2014.02.009CrossRefPubMed

134.

Li J, Zou L, Chen W, Zhu B, Shen N, Ke J, Lou J, Song R, Zhong R, Miao X (2014) Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies. PLoS One 9(4):e93437. https://doi.org/10.1371/journal.pone.0093437CrossRefPubMedPubMedCentral

135.

Fabiani R, Minelli L, Rosignoli P (2016) Apple intake and cancer risk: a systematic review and meta-analysis of observational studies. Public Health Nutr 19(14):2603–2617. https://doi.org/10.1017/s136898001600032xCrossRefPubMed

136.

Le Ngoc TN, Oh YK, Lee YJ, Lee YC (2018) Effects of Sparassis crispa in medical therapeutics: a systematic review and meta-analysis of randomized controlled trials. Int J Mol Sci 19(5):1487. https://doi.org/10.3390/ijms19051487CrossRef

137.

Zhang M, Yang ZY, Binns CW, Lee AH (2002) Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 86(5):712–717. https://doi.org/10.1038/sj.bjc.6600085CrossRefPubMedPubMedCentral

138.

Ren JS, Kamangar F, Forman D, Islami F (2012) Pickled food and risk of gastric cancer- a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomark Prev 21(6):905–915. https://doi.org/10.1158/1055-9965.epi-12-0202CrossRef

139.

Russo M, Spagnuolo C, Tedesco I, Russo GL (2010) Phytochemicals in cancer prevention and therapy: truth or dare? Toxins 2(4):517–551. https://doi.org/10.3390/toxins2040517CrossRefPubMedPubMedCentral

140.

Soundararajan P, Kim JS (2018) Anti-carcinogenic glucosinolates in cruciferous vegetables and their antagonistic effects on prevention of cancers. Molecules 23(11):2983. https://doi.org/10.3390/molecules23112983CrossRefPubMedCentral

141.

Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18(5):957–965. https://doi.org/10.1093/carcin/18.5.957CrossRefPubMed

142.

Reyes-Farias Marjorie, Carrasco-Pozo Catalina (2019) The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci 20(13):3177. https://doi.org/10.3390/ijms20133177CrossRefPubMedCentral

143.

Gunathilake KDPP, Ranaweera KKDS, Vasantha Rupasinghe HP (2018) In vitro anti-inflammatory properties of selected green leafy vegetables. Biomedicines 6(4):107. https://doi.org/10.3390/biomedicines6040107CrossRefPubMedCentral

144.

Kim SH, Choi KC (2013) Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res 29(4):229–234. https://doi.org/10.5487/tr.2013.29.4.229CrossRefPubMedPubMedCentral

145.

Liu H, Liu J, Wang S, Zeng Z, Li T, Liu Y, Mastriani E, Li QH, Bao HX, Zhou YJ, Wang X, Hu S, Gao S, Qi Y, Shen Z, Wang H, Yu M, Gao T, Johnston RN, Liu SL (2017) Enterolactone has stronger effects than enterodiol on ovarian cancer. J Ovarian Res 10(1):49. https://doi.org/10.1186/s13048-017-0346-zCrossRefPubMedPubMedCentral

146.

Sturm C, Wagner AE (2017) Brassica-derived plant bioactives as modulators of chemopreventive and inflammatory signaling pathways. Int J Mol Sci 18(9):1890. https://doi.org/10.3390/ijms18091890CrossRefPubMedCentral

147.

Loganathan S, Kandala PK, Gupta P, Srivastava SK (2012) Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model. PloS One 7(8):e43577. https://doi.org/10.1371/journal.pone.0043577CrossRefPubMedPubMedCentral

148.

Huncharek M, Klassen H, Kupelnick B (2001) Dietary beta-carotene intake and the risk of epithelial ovarian cancer: a meta-analysis of 3,782 subjects from five observational studies. Vivo 15(4):339–343

149.

Cramer DW, Kuper H, Harlow BL, Titus-Ernstoff L (2001) Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women. Int J Cancer 94(1):128–134. https://doi.org/10.1002/ijc.1435CrossRefPubMed

150.

Lee AH, Pasalich M, Su D, Tang L, Tran VD, Binns CW (2013) Mushroom intake and risk of epithelial ovarian cancer in Southern Chinese women. Int J Gynecol Cancer 23(8):1400–1405. https://doi.org/10.1097/IGC.0b013e3182a41dd8CrossRefPubMed

151.

Hetland G, Johnson E, Lyberg T, Bernardshaw S, Tryggestad AM, Grinde B (2008) Effects of the medicinal mushroom Agaricus blazei Murill on immunity, infection and cancer. Scand J Immunol 68(4):363–370. https://doi.org/10.1111/j.1365-3083.2008.02156.xCrossRefPubMed

152.

Dai S, Liu J, Sun X, Wang N (2014) Ganoderma lucidum inhibits proliferation of human ovarian cancer cells by suppressing VEGF expression and up-regulating the expression of connexin 43. BMC Complement Altern Med 14:434. https://doi.org/10.1186/1472-6882-14-434CrossRefPubMedPubMedCentral

153.

Figueiredo L, Régis WCB (2017) Medicinal mushrooms in adjuvant cancer therapies: an approach to anticancer effects and presumed mechanisms of action. Nutrire 42(1):28. https://doi.org/10.1186/s41110-017-0050-1CrossRef

154.

Firenzuoli F, Gori L, Lombardo G (2008) The Medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Altern Med 5(1):3–15. https://doi.org/10.1093/ecam/nem007CrossRef

155.

Wallin A, Orsini N, Wolk A (2011) Red and processed meat consumption and risk of ovarian cancer: a dose-response meta-analysis of prospective studies. Br J Cancer 104(7):1196–1201. https://doi.org/10.1038/bjc.2011.49CrossRefPubMedPubMedCentral

156.

Kolahdooz F, Van Der Pols JC, Bain CJ, Marks GC, Hughes MC, Whiteman DC, Webb PM (2010) Meat, fish, and ovarian cancer risk: results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr 91(6):1752–1763. https://doi.org/10.3945/ajcn.2009.28415CrossRefPubMed

157.

Jiang PY, Jiang ZB, Shen KX, Yue Y (2014) Fish intake and ovarian cancer risk: a meta-analysis of 15 case-control and cohort studies. PLoS One 9(4):e94601. https://doi.org/10.1371/journal.pone.0094601CrossRefPubMedPubMedCentral

158.

zur Hausen H (2012) Red meat consumption and cancer: reasons to suspect involvement of bovine infectious factors in colorectal cancer. Int J Cancer 130(11):2475–2483. https://doi.org/10.1002/ijc.27413CrossRefPubMed

159.

Tavani A, Pelucchi C, Parpinel M, Negri E, Franceschi S, Levi F, La Vecchia C (2003) n-3 polyunsaturated fatty acid intake and cancer risk in Italy and Switzerland. Int J Cancer 105(1):113–116. https://doi.org/10.1002/ijc.11018CrossRefPubMed

160.

Qiu W, Lu H, Qi Y, Wang X (2016) Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Oncotarget 7(24):37390–37406. https://doi.org/10.18632/oncotarget.8940CrossRefPubMedPubMedCentral

161.

Hoang T, Myung SK, Pham TT (2018) Dietary intake of omega-3 fatty acids and endocrine-related gynecological cancer: a meta-analysis of observational studies. Cancer Res Treat. https://doi.org/10.4143/crt.2018.473CrossRefPubMedPubMedCentral

162.

Zeng ST, Guo L, Liu SK, Wang DH, Xi J, Huang P, Liu DT, Gao JF, Feng J, Zhang L (2015) Egg consumption is associated with increased risk of ovarian cancer: evidence from a meta-analysis of observational studies. Clin Nutr 34(4):635–641. https://doi.org/10.1016/j.clnu.2014.07.009CrossRefPubMed

163.

Keum N, Lee DH, Marchand N, Oh H, Liu H, Aune D, Greenwood DC, Giovannucci EL (2015) Egg intake and cancers of the breast, ovary and prostate: a dose-response meta-analysis of prospective observational studies. Br J Nutr 114(7):1099–1107. https://doi.org/10.1017/S0007114515002135CrossRefPubMed

164.

Hu J, La Vecchia C, de Groh M, Negri E, Morrison H, Mery L (2012) Dietary cholesterol intake and cancer. Ann Oncol 23(2):491–500. https://doi.org/10.1093/annonc/mdr155CrossRefPubMed

165.

Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16(1):39–52. https://doi.org/10.1093/carcin/16.1.39CrossRefPubMed

166.

Jeyaraman MM, Abou-Setta AM, Grant L, Farshidfar F, Copstein L, Lys J, Gottschalk T, Desautels D, Czaykowski P, Pitz M, Zarychanski R (2019) Dairy product consumption and development of cancer: an overview of reviews. BMJ Open 9(1):e023625. https://doi.org/10.1136/bmjopen-2018-023625CrossRefPubMedPubMedCentral

167.

Lu W, Chen H, Niu Y, Wu H, Xia D, Wu Y (2016) Dairy products intake and cancer mortality risk: a meta-analysis of 11 population-based cohort studies. Nutr J 15(1):91. https://doi.org/10.1186/s12937-016-0210-9CrossRefPubMedPubMedCentral

168.

Larsson SC, Orsini N, Wolk A (2006) Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies. Int J Cancer 118(2):431–441. https://doi.org/10.1002/ijc.21305CrossRefPubMed

169.

Centeno V, de Barboza GD, Marchionatti A, Rodriguez V, Tolosa de Talamoni N (2009) Molecular mechanisms triggered by low-calcium diets. Nutr Res Rev 22(2):163–174. https://doi.org/10.1017/s0954422409990126CrossRefPubMed

170.

Davoodi H, Esmaeili S, Mortazavian AM (2013) Effects of milk and milk products consumption on cancer: a review. Compr Rev Food Sci Food Saf 12(3):249–264. https://doi.org/10.1111/1541-4337.12011CrossRef

171.

Amiri M, Diekmann L, von Köckritz-Blickwede M, Naim HY (2015) The diverse forms of lactose intolerance and the putative linkage to several cancers. Nutrients 7(9):7209–7230. https://doi.org/10.3390/nu7095332CrossRefPubMedPubMedCentral

172.

Huncharek M, Kupelnick B (2001) Dietary fat intake and risk of epithelial ovarian cancer: a meta-analysis of 6,689 subjects from 8 observational studies. Nutr Cancer 40(2):87–91. https://doi.org/10.1207/s15327914nc402_2CrossRefPubMed

173.

Sadeghi A, Shab-Bidar S, Parohan M, Djafarian K (2019) Dietary fat intake and risk of ovarian cancer: a systematic review and dose-response meta-analysis of observational studies. Nutr Cancer 71(6):939–953. https://doi.org/10.1080/01635581.2019.1595049CrossRefPubMed

174.

Hou R, Wu QJ, Gong TT, Jiang L (2015) Dietary fat and fatty acid intake and epithelial ovarian cancer risk: evidence from epidemiological studies. Oncotarget 6(40):43099–43119. https://doi.org/10.18632/oncotarget.5525CrossRefPubMedPubMedCentral

175.

Tania M, Khan MA, Song Y (2010) Association of lipid metabolism with ovarian cancer. Curr Oncol 17(5):6–11CrossRefPubMedPubMedCentral

176.

Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85(11):1700–1705. https://doi.org/10.1054/bjoc.2001.2140CrossRefPubMedPubMedCentral

177.

Webb PM, Purdie DM, Bain CJ, Green AC (2004) Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 13(4):592–599

178.

Kim HS, Kim JW, Shouten LJ, Larsson SC, Chung HH, Kim YB, Ju W, Park NH, Song YS, Kim SC, Kang SB (2010) Wine drinking and epithelial ovarian cancer risk: a meta-analysis. J Gynecol Oncol 21(2):112–118. https://doi.org/10.3802/jgo.2010.21.2.112CrossRefPubMedPubMedCentral

179.

Rota M, Pasquali E, Scotti L, Pelucchi C, Tramacere I, Islami F, Negri E, Boffetta P, Bellocco R, Corrao G, La Vecchia C, Bagnardi V (2012) Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis. Gynecol Oncol 125(3):758–763. https://doi.org/10.1016/j.ygyno.2012.03.031CrossRefPubMed

180.

de Menezes RF, Bergmann A, Thuler LC (2013) Alcohol consumption and risk of cancer: a systematic literature review. Asian Pac J Cancer Prev 14(9):4965–4972CrossRefPubMed

181.

Yan-Hong H, Jing L, Hong L, Shan-Shan H, Yan L, Ju L (2015) Association between alcohol consumption and the risk of ovarian cancer: a meta-analysis of prospective observational studies. BMC Public Health 15(1):223. https://doi.org/10.1186/s12889-015-1355-8CrossRefPubMedPubMedCentral

182.

Ugai T, Kelemen LE, Mizuno M, Ong JS, Webb PM, Chenevix-Trench G, Wicklund KG, Doherty JA, Rossing MA, Thompson PJ, Wilkens LR, Carney ME, Goodman MT, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Cai H, Shu XO, Gao YT, Xiang YB, Van Den Berg D, Pike MC, Wu AH, Pearce CL, Matsuo K (2018) Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. Cancer Sci 109(2):435–445. https://doi.org/10.1111/cas.13470CrossRefPubMedPubMedCentral

183.

Zheng B, Shen H, Han H, Han T, Qin Y (2018) Dietary fiber intake and reduced risk of ovarian cancer: a meta-analysis. Nutr J 17(1):99. https://doi.org/10.1186/s12937-018-0407-1CrossRefPubMedPubMedCentral

184.

So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK (1996) Inhibition of human breast cancer cell proliferation and delay of mammary tumourigenesis by flavonoids and citrus juices. Nutr Cancer 26(2):167–181. https://doi.org/10.1080/01635589609514473CrossRefPubMed

185.

Guthrie N, Carroll KK (1998) Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol 439:227–236. https://doi.org/10.1007/978-1-4615-5335-9_16CrossRefPubMed

186.

Sak K (2015) In vitro cytotoxic activity of flavonoids on human ovarian cancer cell lines. Cancer Sci Res 2(1):1–13. https://doi.org/10.15226/csroa.2015.00112CrossRef

187.

Mohammadi V, Dehghani S, Larijani B, Azadbakht L (2016) Ovarian cancer risk and nonisoflavone flavonoids intake: a systematic review of epidemiological studies. J Res Med Sci 21:123. https://doi.org/10.4103/1735-1995.196605CrossRefPubMedPubMedCentral

188.

Luo H, Rankin GO, Juliano N, Jiang BH, Chen YC (2012) Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Food Chem 130(2):321–328. https://doi.org/10.1016/j.foodchem.2011.07.045CrossRefPubMedPubMedCentral

189.

Kao YC, Zhou C, Sherman M, Laughton CA, Chen S (1998) Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106(2):85–92. https://doi.org/10.1289/ehp.9810685CrossRefPubMedPubMedCentral

190.

Pang Y, Wang W (2018) Dietary protein intake and risk of ovarian cancer: evidence from a meta-analysis of observational studies. Biosci Rep. https://doi.org/10.1042/bsr20181857CrossRefPubMedPubMedCentral

191.

Ward PP, Paz E, Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 62(22):2540–2548. https://doi.org/10.1007/s00018-005-5369-8CrossRefPubMed

192.

Bounous G (2000) Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res 20(6C):4785–4792PubMed

193.

Peterlik M, Grant WB, Cross HS (2009) Calcium, vitamin D and cancer. Anticancer Res 29(9):3687–3698PubMed

194.

Guo H, Guo J, Xie W, Yuan L, Sheng X (2018) The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention. J Ovarian Res 11(1):1–8. https://doi.org/10.1186/s13048-018-0443-7CrossRef

195.

McCarty MF (2000) Parathyroid hormone may be a cancer promoter- an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D. Med Hypotheses 54(3):475–482. https://doi.org/10.1054/mehy.1999.0880CrossRefPubMed

196.

Cook LS, Neilson HK, Lorenzetti DL, Lee RC (2010) A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol 203(1):70.e71–70.e78. https://doi.org/10.1016/j.ajog.2010.01.062CrossRef

197.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2011) Meta-analysis: circulating vitamin D and ovarian cancer risk. Gynecol Oncol 121(2):369–375. https://doi.org/10.1016/j.ygyno.2011.01.023CrossRefPubMed

198.

Zhou B, Yang L, Wang L, Shi Y, Zhu H, Tang N, Wang B (2007) The association of tea consumption with ovarian cancer risk: a meta-analysis. Am J Obstet Gynecol 197(6):594-e 591–596. https://doi.org/10.1016/j.ajog.2007.05.027

199.

Oppeneer SJ, Robien K (2011) Tea consumption and epithelial ovarian cancer risk: a systematic review of observational studies. Nutr Cancer 63(6):817–826. https://doi.org/10.1080/01635581.2011.594210CrossRefPubMed

200.

Zhang YF, Xu Q, Lu J, Wang P, Zhang HW, Zhou L, Ma XQ, Zhou YH (2015) Tea consumption and the incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Eur J Cancer Prev 24(4):353–362. https://doi.org/10.1097/CEJ.0000000000000094CrossRefPubMed

201.

Xinqiang S, Mu Z, Lei C, Mun LY (2017) Bioinformatics analysis on molecular mechanism of green tea compound epigallocatechin-3-gallate against ovarian cancer. Clin Transl Sci 10(4):302–307. https://doi.org/10.1111/cts.12470CrossRefPubMedPubMedCentral

202.

Schulze J, Melzer L, Smith L, Teschke R (2017) Green tea and its extracts in cancer prevention and treatment. Beverages 3(1):17. https://doi.org/10.3390/beverages3010017CrossRef

203.

Wang A, Wang S, Zhu C, Huang H, Wu L, Wan X, Yang X, Zhang H, Miao R, He L, Sang X, Zhao H (2016) Coffee and cancer risk: a meta-analysis of prospective observational studies. Sci Rep 6:33711. https://doi.org/10.1038/srep33711CrossRefPubMedPubMedCentral

204.

Berretta M, Micek A, Lafranconi A, Rossetti S, Di Francia R, De Paoli P, Rossi P, Facchini G (2018) Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies. Oncotarget 9(29):20807–20815. https://doi.org/10.18632/oncotarget.24829CrossRefPubMedPubMedCentral

205.

Yu X, Bao Z, Zou J, Dong J (2011) Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11:96. https://doi.org/10.1186/1471-2407-11-96CrossRefPubMedPubMedCentral

206.

Salari-Moghaddam A, Milajerdi A, Surkan PJ, Larijani B, Esmaillzadeh A (2019) Caffeine, type of coffee, and risk of ovarian cancer: a dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab 104(11):5349–5359. https://doi.org/10.1210/jc.2019-00637CrossRefPubMed

207.

Pelucchi C, Bosetti C, Galeone C, La Vecchia C (2015) Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer 136(12):2912–2922. https://doi.org/10.1002/ijc.29339CrossRefPubMed

208.

Pelucchi C, La Vecchia C, Bosetti C, Boyle P, Boffetta P (2011) Exposure to acrylamide and human cancer- a review and meta-analysis of epidemiologic studies. Ann Oncol 22(7):1487–1499. https://doi.org/10.1093/annonc/mdq610CrossRefPubMed

209.

Virk-Baker MK, Nagy TR, Barnes S, Groopman J (2014) Dietary acrylamide and human cancer: a systematic review of literature. Nutr Cancer 66(5):774–790. https://doi.org/10.1080/01635581.2014.916323CrossRefPubMedPubMedCentral

210.

Xie L, Mo M, Jia HX, Liang F, Yuan J, Zhu J (2016) Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies. Oncotarget 7(35):56915–56932. https://doi.org/10.18632/oncotarget.10917CrossRefPubMedPubMedCentral

211.

Sathiakumar N, MacLennan PA, Mandel J, Delzell E (2011) A review of epidemiologic studies of triazine herbicides and cancer. Crit Rev Toxicol 41(Suppl 1):1–34. https://doi.org/10.3109/10408444.2011.554793CrossRefPubMed

212.

Semren TZ, Zunec S, Pizent A (2018) Oxidative stress in triazine pesticide toxicity: a review of the main biomarker findings. Arh Hig Rada Toksikol 69(2):109–125. https://doi.org/10.2478/aiht-2018-69-3118CrossRefPubMed

213.

Huang P, Yang J, Ning J, Wang M, Song Q (2015) Atrazine triggers DNA damage response and induces DNA double-strand breaks in MCF-10A cells. Int J Mol Sci 16(7):14353–14368. https://doi.org/10.3390/ijms160714353CrossRefPubMedPubMedCentral

214.

Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM (2008) Dietary glycaemic index, glycaemic load and endometrial and ovarian cancer risk: a systematic review and meta-analysis. Br J Cancer 99(3):434–441. https://doi.org/10.1038/sj.bjc.6604496CrossRefPubMedPubMedCentral

215.

Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM, Bandera EV (2015) Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African-American women. Br J Nutr 115(4):694–702. https://doi.org/10.1017/S0007114515004882CrossRefPubMedPubMedCentral

216.

Cui X, Rosner B, Willett WC, Hankinson SE (2010) Dietary fat, fiber, and carbohydrate intake and endogenous hormone levels in premenopausal women. Horm Cancer 1(5):265–276. https://doi.org/10.1007/s12672-010-0050-6CrossRefPubMedPubMedCentral

217.

Doldo E, Costanza G, Agostinelli S, Tarquini C, Ferlosio A, Arcuri G, Passeri D, Scioli MG, Orlandi A (2015) Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins. BioMed Res Int. https://doi.org/10.1155/2015/624627CrossRefPubMedPubMedCentral

Title: Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
Authors: Alireza Khodavandi
Fahimeh Alizadeh
Ahmad Faizal Abdull Razis
Publication date: 01-06-2021
Publisher: Springer Berlin Heidelberg
Keywords: Ovarian Cancer
Ovarian Cancer
Published in: European Journal of Nutrition / Issue 4/2021
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-020-02332-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2021

The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double-blind, placebo-controlled randomized clinical trial

Association between per capita sugar consumption and diabetes prevalence mediated by the body mass index: results of a global mediation analysis

Betaine and choline status modify the effects of folic acid and creatine supplementation on arsenic methylation in a randomized controlled trial of Bangladeshi adults

Relationship between salt consumption and iodine intake in a pediatric population

Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial

Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipients

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials